GTHX – ASCO21 as cancer biotech catalyst

Read the Story

Show Top Comments

Holding 500 @ 24.41 and strongly believing in G1. Looking forward to June 4th!


Одна из самых перспективных акций на данный момент. Возлагаю большие надежды на ASCO


I think we are gonna see +100% to this position in a year or less 😉


I don’t have such paper, perhaps I need to buy some


What makes small biotechs push forward clinical trials with bad results at previous trials? I think, only good expectations about new data and some insider information about previous trials. Who knows – does company can improve/change formula of their candidate prior to new trial?